Last reviewed · How we verify

Hyadent BG

University of Zagreb · Phase 3 active Small molecule

Hyadent BG is a hyaluronic acid-based biomaterial designed to promote bone and periodontal tissue regeneration.

Hyadent BG is a hyaluronic acid-based biomaterial designed to promote bone and periodontal tissue regeneration. Used for Periodontal bone defects, Alveolar bone regeneration.

At a glance

Generic nameHyadent BG
SponsorUniversity of Zagreb
Drug classBiomaterial/Regenerative medicine product
ModalitySmall molecule
Therapeutic areaDentistry/Periodontal/Bone regeneration
PhasePhase 3

Mechanism of action

The drug functions as a scaffold material that supports the growth and differentiation of bone and periodontal cells. Hyaluronic acid serves as an extracellular matrix component that facilitates cell adhesion, migration, and tissue formation in dental and bone defect sites.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results